US Stock MarketDetailed Quotes

TPH Tri Pointe Homes

Watchlist
  • 31.660
  • +0.450+1.44%
Close Feb 28 16:00 ET
  • 31.661
  • +0.001+0.00%
Post 20:01 ET
2.91BMarket Cap6.55P/E (TTM)

Tri Pointe Homes Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tri Pointe Homes Q4 2024 Earnings Date

Currency：USDFeb 18, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.22B
1.25B
+38.10M
Beat Est.
-2.25%
-0.46%
+3.13%
EPS
1.29
1.37
+0.08
Beat Est.
-5.36%
+0.74%
+6.44%
Analyst Rating
Buy

Feb 28, 2025

Tri Pointe Homes Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 904.567M--
--2025/Q1-- / 713.650M--
Feb 18, 20252024/Q41.231B / 1.216B--
Oct 24, 20242024/Q31.127B / 1.053B--
Jul 25, 20242024/Q21.138B / 1.066B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 904.567M--
--2025/Q1-- / 713.650M--
Feb 18, 20252024/Q41.231B / 1.216B--
Oct 24, 20242024/Q31.127B / 1.053B--
Jul 25, 20242024/Q21.138B / 1.066B--

Unlock Free Earnings Estimates

Tri Pointe Homes Earnings Reports

  • Tri Pointe Homes | 10-K: FY2024 Annual Report

    Feb 21 17:27 ET

  • Tri Pointe Homes | 8-K: TRI POINTE HOMES, INC. REPORTS 2024 FOURTH QUARTER AND FULL YEAR RESULTS

    Feb 18 08:41 ET

  • Tri Pointe Homes | 10-Q: Q3 2024 Earnings Report

    Oct 24, 2024 17:14 ET

  • Tri Pointe Homes | 10-Q: Q2 2024 Earnings Report

    Jul 25, 2024 16:44 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Buy

    • Buy

      25.00%

    • Hold

      75.00%

    • Sell

      0.00%

    Price Target

    No Data